Thumbnail Image
Item

Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)

Cavalli, Eugenio
; 
Bramanti, Alessia
; 
Ciurleo, Rosella
; 
Tchorbanov, Andrey I.
; ; 
Fagone, Paolo
; 
Belizna, Cristina
; 
Bramanti, Placido
; 
Shoenfeld, Yehuda
; 
Nicoletti, Ferdinando
Citations
Altmetric:
Genre
Journal article
Date
2020-06-25
Advisor
Committee member
Group
Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine (Temple University)
Department
Subject
Acute respiratory distress syndrome
 Anti‑cardiolipin autoantibodies
 Anti‑β2 glycoprotein 1 autoantibodies
 Anti‑phospholipid autoantibodies
 Anti‑phospholipid syndrome
 Coagulopathy
 COVID‑ 19
 Disseminated intravascular coagulation
 Severe acute respiratory syndrome coronavirus 2
 Pneumonia
 Thromboembolism
 Stroke
Permanent link to this record
http://hdl.handle.net/20.500.12613/251
Collections
COVID-19 Research
Show all metadata
Files
Thumbnail Image
Giordano-JournalArticle-2020-06.pdf
Adobe PDF, 520.28 KB
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.3892/ijmm.2020.4659
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a novel β coronavirus that is the etiological agent of the pandemic coronavirus disease 2019 (COVID‑19) that at the time of writing (June 16, 2020) has infected almost 6 million people with some 450,000 deaths. These numbers are still rising daily. Most (some 80%) cases of COVID‑19 infection are asymptomatic, a substantial number of cases (15%) require hospitalization and an additional fraction of patients (5%) need recovery in intensive care units. Mortality for COVID‑19 infection appears to occur globally between 0.1 and 0.5% of infected patients although the frequency of lethality is significantly augmented in the elderly and in patients with other comorbidities. The development of acute respiratory distress syndrome and episodes of thromboembolism that may lead to disseminated intravascular coagulation (DIC) represent the primary causes of lethality during COVID‑19 infection. Increasing evidence suggests that thrombotic diathesis is due to multiple derangements of the coagulation system including marked elevation of D‑dimer that correlate negatively with survival. We propose here that the thromboembolic events and eventually the development of DIC provoked by SARS‑CoV‑2 infection may represent a secondary anti‑phospholipid antibody syndrome (APS). We will apply both Baconian inductivism and Cartesian deductivism to prove that secondary APS is likely responsible for coagulopathy during the course of COVID‑19 infection. Diagnostic and therapeutic implications of this are also discussed.
Description
Citation
Cavalli E, Bramanti A, Ciurleo R, Tchorbanov AI, Giordano A, Fagone P, Belizna C, Bramanti P, Shoenfeld Y, Nicoletti F, Nicoletti F, et al: Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review). Int J Mol Med 46: 903-912, 2020
Citation to related work
Spandidos Publications
Has part
International Journal of Molecular Medicine, Vol. 46, Issue 3
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
Embedded videos